These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33342591)

  • 1. Cannabis use is associated with reduced risk of exposure to fentanyl among people on opioid agonist therapy during a community-wide overdose crisis.
    Socías ME; Choi J; Lake S; Wood E; Valleriani J; Hayashi K; Kerr T; Milloy MJ
    Drug Alcohol Depend; 2021 Feb; 219():108420. PubMed ID: 33342591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.
    Socías ME; Wood E; Lake S; Nolan S; Fairbairn N; Hayashi K; Shulha HP; Liu S; Kerr T; Milloy MJ
    Addiction; 2018 Dec; 113(12):2250-2258. PubMed ID: 30238568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting.
    Mackay L; Kerr T; Fairbairn N; Grant C; Milloy MJ; Hayashi K
    Addict Sci Clin Pract; 2021 Apr; 16(1):26. PubMed ID: 33910630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada.
    Brar R; Grant C; DeBeck K; Milloy MJ; Fairbairn N; Wood E; Kerr T; Hayashi K
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):625-631. PubMed ID: 32689810
    [No Abstract]   [Full Text] [Related]  

  • 5. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study.
    Hayashi K; Milloy MJ; Lysyshyn M; DeBeck K; Nosova E; Wood E; Kerr T
    Drug Alcohol Depend; 2018 Feb; 183():1-6. PubMed ID: 29220642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015-2016.
    Smolina K; Crabtree A; Chong M; Zhao B; Park M; Mill C; Schütz CG
    Drug Alcohol Depend; 2019 Jan; 194():151-158. PubMed ID: 30439611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine/naloxone associated with a reduced odds of fentanyl exposure among a cohort of people who use drugs in Vancouver, Canada.
    Young S; Hayashi K; Grant C; Milloy MJ; DeBeck K; Wood E; Fairbairn N
    Drug Alcohol Depend; 2021 Nov; 228():109006. PubMed ID: 34509737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.
    Bozinoff N; DeBeck K; Milloy MJ; Nosova E; Fairbairn N; Wood E; Hayashi K
    Drug Alcohol Depend; 2018 Dec; 193():42-47. PubMed ID: 30340144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and longitudinal correlates of recent exposure to fentanyl among HIV-positive people who use unregulated drugs during a community-wide overdose crisis.
    Moallef S; Nosova E; Nolan S; Fairbairn N; Loh J; Hayashi K; Milloy MJ
    AIDS Care; 2021 Dec; 33(12):1560-1568. PubMed ID: 33764814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting.
    Dong H; Hayashi K; Milloy MJ; DeBeck K; Singer J; Wong H; Wood E; Kerr T
    Drug Alcohol Depend; 2020 Jul; 212():108005. PubMed ID: 32370932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting.
    Hayashi K; Wood E; Dong H; Buxton JA; Fairbairn N; DeBeck K; Milloy MJ; Kerr T
    Drug Alcohol Rev; 2021 Sep; 40(6):964-973. PubMed ID: 33604968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.
    Pearce LA; Min JE; Piske M; Zhou H; Homayra F; Slaunwhite A; Irvine M; McGowan G; Nosyk B
    BMJ; 2020 Mar; 368():m772. PubMed ID: 32234712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Increasing Prevalence of Fentanyl: A Urinalysis-Based Study Among Individuals With Opioid Use Disorder in New York City.
    Martinez S; Jones JD; Brandt L; Campbell ANC; Abbott R; Comer SD
    Am J Addict; 2021 Jan; 30(1):65-71. PubMed ID: 32776640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis.
    Lake S; Walsh Z; Kerr T; Cooper ZD; Buxton J; Wood E; Ware MA; Milloy MJ
    PLoS Med; 2019 Nov; 16(11):e1002967. PubMed ID: 31743343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy.
    Moallef S; DeBeck K; Fairbairn N; Cui Z; Brar R; Wilson D; Johnson C; Milloy MJ; Hayashi K
    Addict Sci Clin Pract; 2022 Dec; 17(1):73. PubMed ID: 36522789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
    Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
    Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
    [No Abstract]   [Full Text] [Related]  

  • 17. Increasing preference for fentanyl among a cohort of people who use opioids in Vancouver, Canada, 2017-2018.
    Ickowicz S; Kerr T; Grant C; Milloy MJ; Wood E; Hayashi K
    Subst Abus; 2022; 43(1):458-464. PubMed ID: 34283705
    [No Abstract]   [Full Text] [Related]  

  • 18. Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada.
    Cui Z; Bach P; Ti L; Hayashi K; Morgan J; Milloy MJ; Kerr T
    Int J Drug Policy; 2022 Dec; 110():103879. PubMed ID: 36265327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid agonist treatment and the process of injection drug use initiation.
    Mittal ML; Jain S; Sun S; DeBeck K; Milloy MJ; Hayashi K; Hadland SE; Werb D
    Drug Alcohol Depend; 2019 Apr; 197():354-360. PubMed ID: 30922483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.
    Socías ME; Wood E; Kerr T; Nolan S; Hayashi K; Nosova E; Montaner J; Milloy MJ
    Drug Alcohol Depend; 2018 Aug; 189():90-95. PubMed ID: 29894910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.